Sort
53,477 grants matching “addiction”
Yale/NIDA Neuroproteomics Research Center
$1,624,122Kenneth Robert Williams · Yale University · P30 · FY2012 · DA
Predicting fatal and non-fatal overdose in Los Angeles County with Rapid Overdose Surveillance Dashboard to target street-based addiction treatment and harm reduction services
$1,624,120Chelsea Leigh Shover · University Of California Los Angeles · R01 · FY2022 · DA
Yale/NIDA Neuroproteomics Research Center
$1,622,975Kenneth Robert Williams · Yale University · P30 · FY2011 · DA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,621,237Luis J. Montaner · Wistar Institute · R01 · FY2023 · DA
Wake Forest NCORP Research Base
$1,620,862Glenn J Lesser · Wake Forest University Health Sciences · UG1 · FY2021 · CA
The Healthy Brain and Child Development National Consortium Administrative Core
$1,620,783Christina Chambers · University Of California, San Diego · U24 · FY2023 · DA
Addressing the chronic pain epidemic among older adults in underserved community center; The GetActive+ study.
$1,620,259Ana-Maria Vranceanu · Massachusetts General Hospital · R61 · FY2022 · AG
Oxytocin: a pain disease-modifying agent in the nervous system after injury
$1,620,081Thomas J Martin · Wake Forest University Health Sciences · P01 · FY2024 · NS
Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor
$1,619,246Lei Shi · National Institute On Drug Abuse · ZIA · FY2018 · DA
National Resource for Mass Spectrom of Biological Macromolecules
$1,619,191Brian T Chait · Rockefeller University · P41 · FY2016 · GM
National Resource for Mass Spectrom of Biological Macromolecules
$1,617,191Brian T Chait · Rockefeller University · P41 · FY2017 · GM
Center for the Neurobiology of Addiction Treatment
$1,617,079Steven R Childers · Wake Forest University Health Sciences · P50 · FY2015 · DA
A Cohort-Sequential Panal Study of Drug Use, Ages 19-50
$1,617,039Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2011 · DA
C57BI/6 Mouse Lines Expressing CRE-Recombinase in the Nervous System
$1,616,272Ulrich Mueller · Scripps Research Institute, The · U01 · FY2010 · MH
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2024 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2022 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2021 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2020 · DA
Yale/NIDA Neuroproteomics Center
$1,616,094Kenneth Robert Williams · Yale University · P30 · FY2023 · DA
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$1,615,108Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2011 · DA
Novel LAAM formulations to treat Opioid Use Disorder (UG3 DA048768-01A1)
$1,614,668Qingguo Xu · Virginia Commonwealth University · UG3 · FY2019 · DA
12/24 Healthy Brain and Child Development National Consortium
$1,611,837Elinor L. Sullivan · Oregon Health & Science University · U01 · FY2025 · DA
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program
$1,611,440Lorenzo Leggio · National Institute On Drug Abuse · ZID · FY2023 · DA
The Collaborative Genetic Study of Nicotine Dependence
$1,610,967Laura Jean Bierut · Washington University · P01 · FY2010 · CA
Treatments For Complex Patients In New Settings
$1,609,450Sharon M. Hall · University Of California, San Francisco · P50 · FY2008 · DA